Shorter antibiotic courses non-inferior for inpatient community-acquired pneumonia
1. In this target trial emulation, a shorter antibiotic course (3 to 4 days) demonstrated a similar 30-day all-cause mortality...
1. In this target trial emulation, a shorter antibiotic course (3 to 4 days) demonstrated a similar 30-day all-cause mortality...
1. A next-generation live-attenuated yellow fever vaccine (vYF) demonstrated noninferior immunogenicity compared to the standard vaccine, with nearly universal seroconversion...
1. In this phase 3, randomized, placebo-controlled trial, an antiviral medication approved for treating smallpox (tecovirimat) did not accelerate clinical...
1. In this cohort study, the quadrivalent human papillomavirus (HPV) vaccine provides strong, long-lasting protection against invasive cervical cancer, with...
1. In this randomized controlled trial, neither metformin nor ursodeoxycholic acid improved recovery from long COVID compared with placebo in...
1. Poly-L-lysine (PLL)-coated catheters are well-tolerated, safe, and noninferior in preventing bacteriuria compared to noble metal alloys (NMA)-coated catheters in...
1. Among patients with sepsis-associated encephalopathy, propofol monotherapy was associated with lower one-year all-cause mortality compared to no sedation therapy....
1. Mobile telemedicine was associated with significantly higher chances of initiating hepatitis C virus (HCV) treatment and achieving viral clearance...
1. Adjunctive fluoxetine significantly reduced vasopressor duration and ICU length of stay in patients with severe sepsis. 2. Fluoxetine improved...
1. Children and adolescents with chronic medical conditions have a significantly higher risk of invasive pneumococcal disease, particularly those who...
3-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Monthly plan selected: $4.99 /month.
3-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
Yearly plan selected: $49.90 /year.
2 months free
Then $49.90/year.
Already a member? Sign in